Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2171019-55-7
2. Afimetoran [usan]
3. Lxp7mzl0vf
4. Bms-986256
5. Unii-lxp7mzl0vf
6. Afimetoran [inn]
7. Bms 986256
8. Afimetoran (usan)
9. 2-(4-(2-(7,8-dimethyl(1,2,4)triazolo(1,5-a)pyridin-6-yl)-3-(propan-2-yl)-1h-indol-5-yl)piperidin-1-yl)acetamide
10. 1-piperidineacetamide, 4-(2-(7,8-dimethyl(1,2,4)triazolo(1,5-a)pyridin-6-yl)-3-(1-methylethyl)-1h-indol-5-yl)-
11. Refchem:110007
12. 2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1h-indol-5-yl)piperidin-1-yl)acetamide
13. Who 11516
14. 2-[4-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1h-indol-5-yl]piperidin-1-yl]acetamide
15. 1-piperidineacetamide, 4-(2-(7,8-dimethyl(1,2,4)triazolo(1,5-a)pyridin-6-yl)-3- (1-methylethyl)-1h-indol-5-yl)-
16. Afimetoran [who-dd]
17. Orb1303504
18. Afimetoran (bms-986256)
19. Chembl4650329
20. Schembl19761011
21. C26h32n6o
22. Bdbm273241
23. Ex-a6745
24. Us10071079, Example 15
25. Mfcd34578322
26. Akos040757385
27. Da-70624
28. Ms-28017
29. Hy-139567
30. Cs-0213544
31. D11908
32. G18517
33. 2-(4-(2-(7,8-dimethyl(1,2,4)triazolo(1,5-a)pyridin-6-yl)-3-(propan-2-yl)-1h-indol- 5-yl)piperidin-1-yl)acetamide
34. 2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1h-indol-5-yl) Piperidin-1-yl)acetamide
35. 2-[4-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1h-indol-5-yl]-1-piperidyl]acetamide
| Molecular Weight | 444.6 g/mol |
|---|---|
| Molecular Formula | C26H32N6O |
| XLogP3 | 3.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 92.3 |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 694 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Afimetoran acts as an antagonist of TLR 7/8.
ABOUT THIS PAGE
42
PharmaCompass offers a list of Afimetoran API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Afimetoran manufacturer or Afimetoran supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Afimetoran manufacturer or Afimetoran supplier.
A Afimetoran manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Afimetoran, including repackagers and relabelers. The FDA regulates Afimetoran manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Afimetoran API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Afimetoran supplier is an individual or a company that provides Afimetoran active pharmaceutical ingredient (API) or Afimetoran finished formulations upon request. The Afimetoran suppliers may include Afimetoran API manufacturers, exporters, distributors and traders.
Afimetoran Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Afimetoran GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Afimetoran GMP manufacturer or Afimetoran GMP API supplier for your needs.
A Afimetoran CoA (Certificate of Analysis) is a formal document that attests to Afimetoran's compliance with Afimetoran specifications and serves as a tool for batch-level quality control.
Afimetoran CoA mostly includes findings from lab analyses of a specific batch. For each Afimetoran CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Afimetoran may be tested according to a variety of international standards, such as European Pharmacopoeia (Afimetoran EP), Afimetoran JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Afimetoran USP).
